MAPK8 and cardiac hypertrophy: In cardiomyocytes treated with high glucose, the inhibition of miR-200c-3p led to the overexpression of DUSP1 and the low expression of p-ERK1/2, p-P38, and p-JNK, thus attenuating the cardiac hypertrophy (39).